Acadia Healthcare

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services. The U.K. Facilities segment provides inpatient services through facilities, including mental health hospitals, clinics, care homes, schools, colleges, and children's homes. The company was founded in January 2005 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Acadia Healthcare posts robust Q4 results, eyes growth opportunities ahead

Acadia Healthcare's strong Q4 performance, growth strategies, and financial stability position it well for future expansion and success in the healthcare sector.
While facing challenges such as labor costs and Medicaid redeterminations, the company's focus on IT investments, strategic partnerships, and revenue diversification mitigates risks.
Opportunities in M&A, value-based programs, and revenue growth present avenues for Acadia to capitalize on market trends, enhance patient care, and drive shareholder value.

Acadia Healthcare excels in Q1 2023, navigates challenges for growth

Acadia Healthcare's strong Q1 performance, robust financial position, and strategic growth initiatives position the company for continued success and resilience.
While facing challenges such as labor inflation and benefit cost increases, Acadia's proactive approach and focus on efficiency and optimization are key to maintaining profitability.
Opportunities in expanding CTC business, achieving Medicaid rate increases, and leveraging investments in technology and marketing underscore Acadia's potential for sustained growth and operational excellence.

Acadia Healthcare excels in Q2 2023, eyes growth opportunities

Acadia Healthcare's Q2 2023 performance reflects strong financial growth and operational excellence.
The company's focus on quality care, technology, and strategic acquisitions positions it for continued success.
While facing challenges like regulatory uncertainties, Acadia Healthcare remains committed to growth and value creation.
Opportunities for expansion through acquisitions, partnerships, and operational enhancements are key focus areas for future growth.

Acadia Healthcare reports robust Q3 results and outlines growth strategies

Acadia Healthcare's Q3 performance reflects strong revenue and earnings growth, supported by operational efficiency and cost management.
While facing challenges such as start-up costs and operating expenses, the company is well-positioned to capitalize on growth opportunities.
Strategic initiatives in employee engagement, partnerships, and digitization highlight Acadia's commitment to sustainable growth and patient care.
Overall, Acadia's financial outlook remains positive, with a focus on expansion, cost optimization, and enhancing healthcare services.

Acadia Healthcare reports strong Q4 earnings and outlines growth plans

Acadia Healthcare delivered strong financial results in Q4 2023, with revenue growth, improved EBITDA, and EPS, driven by same facility revenue growth and strategic initiatives.
The company's focus on quality care, technology investments, and expansion plans position it well for continued growth and market leadership in the behavioral health care sector.
While facing challenges in labor expenses and seasonal impacts, Acadia's opportunities for growth through expansions, CTC services, and partnerships signal a positive outlook for 2024.
Overall, Acadia Healthcare's performance, strengths, and opportunities indicate a promising trajectory for sustained growth and profitability in the coming year.

Acadia Healthcare reports robust Q1 growth amidst strategic expansions

Acadia Healthcare delivered strong financial performance in Q1 2024, with revenue, EBITDA, and EPS showing significant growth. The company's strategic focus on expansion, acquisitions, and service enhancements contributed to its positive results.
While facing challenges with patient volumes and overhead costs, Acadia remains resilient and anticipates a stronger performance in the latter half of the year. Opportunities for growth through facility expansions, technology investments, and funding support position the company for continued success.
Overall, Acadia Healthcare's Q1 earnings call highlights its solid performance, strategic strengths, ongoing challenges, and promising opportunities for future growth. The company's commitment to delivering value to stakeholders and enhancing patient care underscores its position in the healthcare industry.

Acadia Healthcare posts robust Q3 results amidst legal challenges and growth opportunities

Acadia Healthcare's Q3 2024 performance reflects solid revenue growth and EBITDA expansion, underpinned by a commitment to quality care and operational efficiency.
While facing challenges from legal issues and lower volume growth, the company is actively addressing these hurdles and investing in future growth opportunities.
By navigating challenges, leveraging strengths, and capitalizing on growth opportunities, Acadia Healthcare is poised for continued success in the behavioral health care sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.

LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Has Launched An Inquiry Into Whether Acadia Healthcare Company Inc. Committed Securities Fraud And Investors With Losses Can Reach Out

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is honored to share that seven of its facilities were named on Newsweek's list of America's Best Addiction Treatment Centers 2024. Many of these treatment centers have earned a spot on this prestigious list in the past as well. The recognized addiction centers are located across five states: Arizona: Sierra Tucson California: Bayside Marin Treatment Center & Azure Acres Recovery Center North Carolina: Wilmingto.

Seven Acadia Healthcare Facilities Recognized in Newsweek's 2024 Best Addiction Treatment Center List

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Acadia Healthcare Company, Inc.(ACHC) And Encourages Stockholders to Connect

Forrester Research

PETOSKEY, Mich.--(BUSINESS WIRE)-- #affordablehousing--Victories Square is a tribal housing development in Petoskey, Michigan, that will provide affordable housing for 50 low-income families.

Hunt Capital Partners Provide $13 Million in LIHTC Financing for Tribal Housing in Petoskey, Michigan

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.

ATTENTION ACHC SHAREHOLDERS: Investors who lost money on Acadia Healthcare Company, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

NEW YORK, NY / ACCESSWIRE / September 8, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Acadia Healthcare Company, Inc.(ACHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Acadia Healthcare Company, Inc Is Being Looked Into For Securities Related Improprieties And Stakeholders Are Invited To Play A Part

NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) on behalf of Acadia stockholders. Our investigation concerns whether Acadia has violated the federal securities laws and/or engaged in other unlawful business practices.

ACADIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Acadia Healthcare Company, Inc. on Behalf of Acadia Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)---- $ACHC #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC). The investigation concerns whether Acadia and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On September 1, 2024, The New York Times published a report on Acadia, one of the largest chains of.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Acadia Healthcare Company, Inc. (ACHC)

NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Acadia Healthcare Company, Inc. (ACHC) and Encourages Stockholders to Learn More About the Investigation

LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Investors Can Join The Schall Law Firm In An Inquiry Into Acadia Healthcare Company Inc. For Possible Securities Law Infractions

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Acadia Healthcare Company, Inc. ("Acadia Healthcare Company, Inc.") (NASDAQ:ACHC) concerning possible violations of federal securities laws. The New York Times published a report on September 1, 2024, entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients.

Acadia Healthcare Company, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ACHC

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Bronstein, Gewirtz & Grossman, LLC Encourages Acadia Healthcare Company, Inc.(ACHC) Investors to Inquire about Securities Investigation

LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm Is Looking Into Whether Acadia Healthcare Company Inc Violated Securities Laws And Shareholders Are Invited To Reach Out

NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ACHC.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Acadia Healthcare Company, Inc.(ACHC) And Encourages Investors to Reach Out

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) resulting from allegations that Acadia Healthcare may have issued materially misleading business information to the investing public. So What: If you purchased Acadia Healthcare securities you may be entitled to compensation without payment of any out of pocket fees or costs throug.

Rosen Law Firm Encourages Acadia Healthcare Company, Inc. Investors to Inquire About Securities Class Action Investigation – ACHC

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?

Why Is Acadia Healthcare (ACHC) Up 9.1% Since Last Earnings Report?

ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System.

Acadia Healthcare Expands Behavioral Health Services in Iowa

COUNCIL BLUFFS, Iowa--(BUSINESS WIRE)--Methodist Jennie Edmundson Hospital and Acadia Healthcare Company held a groundbreaking ceremony today for a state-of-the-art behavioral health hospital serving western Iowa and eastern Nebraska residents. The event occurred on the site of the future hospital at 3620 S. 24th St. in Council Bluffs, Iowa, and celebrated the previously announced joint-venture partnership between Methodist and Acadia Healthcare. Methodist Jennie Edmundson Hospital is an affili.

Methodist and Acadia Healthcare Break Ground on Behavioral Health Hospital in Council Bluffs

Community Health Systems

HCA Healthcare

Tenet Healthcare

Universal Health Services

The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.

5 Hospital Stocks Poised to Benefit From Strong Industry Growth

Acadia Healthcare (ACHC) remains well-poised for growth on the back of the solid demand for behavioral healthcare services, continuous pursuit of expansion initiatives and a notable financial position.

Here's Why Investors Should Hold Acadia (ACHC) Stock for Now

Acadia Healthcare's (ACHC) Q2 results reflect higher revenue per patient day and increased patient days. It currently estimates 2024 adjusted EPS within $3.45-$3.65 compared with the earlier view of $3.40-$3.70.

Acadia Healthcare (ACHC) Shares Up 12% on Q2 Earnings Beat

Acadia Healthcare Company, Inc (NASDAQ:ACHC ) Q2 2024 Results Conference Call August 1, 2024 9:00 AM ET Company Participants Patrick Feeley - Head of Investor Relations Chris Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners A.J. Rice - UBS Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Ben Hendrix - RBC Capital Markets John Ransom - Raymond James Scott Fidel - Stephens Pito Chickering - Deutsche Bank Andrew Mok - Barclays Sarah James - Cantor Fitzgerald Ryan Langston - TD Cowen Operator Good day, and welcome to Acadia Healthcare's Second Quarter of 2024 Earnings Call.

Acadia Healthcare Company, Inc (ACHC) Q2 2024 Earnings Call Transcript

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.92 per share a year ago.

Acadia Healthcare (ACHC) Beats Q2 Earnings and Revenue Estimates

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Highlights Revenue totaled $796.0 million, an increase of 8.8% over the second quarter of 2023 Same facility revenue increased 8.3% compared with the second quarter of 2023, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.6% Net income attributable to Acadia total.

News for Acadia Healthcare Stock (ACHC)